JUL 05, 2018 6:13 AM PDT

Is Testing Everyone for Hep C Necessary?

Cases of Hepatitis C, known as Hep C or HCV, are on the rise. In the United States, the CDC reports that there were approximately 3,000 new cases of hepatitis C in 2016. In the US about 3.5 million people are living with the virus. Worldwide the number is estimated at 71 million.

The World Health Organization figures show that between 15 and 45 percent of those who contract HCV will recover within six months and many never realize they are infected. It's spread via contact with the blood of an infected person and needle sharing among IV drug users is a common cause. Those who do not recover from the infection often go on to develop chronic HCV which increases the risk of cirrhosis of the liver and liver cancer. Every year between 350,000 and 500,000 people die from HCV complications.

In Canada, the Canadian Treatment Action Council (CTAC) has launched an effort to end Hep C infections in Canada. They listed seven calls-to-action in a white paper  on the epidemic, one of which is "Increased access to testing, including point-of-care testing, rapid testing, and one-time cohort screening for all baby boomers." Dr. Jordan Feld is a liver specialist at Toronto's University Health Network and a co-author of the recently issued guidelines that recommend every patient born between 19945 and 1975 be tested for the virus. In an interview with CBC, Feld stated, "And the reason we've done this is it just happens that somewhere between two-thirds and three-quarters of people with hepatitis C were born between 1945 and 1975 in Canada. So just the way someone gets a blood pressure check or a cholesterol check or a colonoscopy based on their age, we would recommend that they get a hepatitis C test if they're born between those years."

Not everyone agrees, however. In 2017, the Canadian Task Force on Preventative Health Care recommended against testing all citizens, stating that only those at risk should be screened. In an interview with Reuters in April 2017, Task Force member Dr. Roland Grad stated, "For the average Canadian at average risk, don't screen." Liver experts in Canada disagree, saying that risk is difficult to assess and if patients are not screened and develop symptoms later, the disease has likely progressed too far for the use of newer drugs called "direct action antivirals" that can clear HCV from 95% of patients in 8-12 weeks. While the disease continues to be a problem in Canada and in other countries, the newer drugs are quite expensive and not always covered (https://www.labroots.com/trending/health-and-medicine/11754/insurance-denials-prevent-patients-getting-hep-medication) by insurance plans. In Canada, access to the drugs is guaranteed for Canadians under their national health plan.

The video below talks more about testing and who should consider it. As always, check with your doctor about your risk.

Sources: CBC Canadian Treatment Action Council  World Health Organization CDC

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
MAR 26, 2021
Cell & Molecular Biology
New 'Bio-ink' Gets 3D-Printed Organs Closer to Reality
MAR 26, 2021
New 'Bio-ink' Gets 3D-Printed Organs Closer to Reality
For the many people waiting for transplants, 3D-printed organs can't come soon enough. Researchers have been making stri ...
MAR 28, 2021
Cell & Molecular Biology
Understanding How Cold-Induced Tooth Pain Happens
MAR 28, 2021
Understanding How Cold-Induced Tooth Pain Happens
Our teeth do a lot of work, and they may become sensitive to cold as the gums erode due to aging or because they have an ...
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
APR 12, 2021
Health & Medicine
Chronic Pain Patients Can Find Long-Term Success Using Cannabis
APR 12, 2021
Chronic Pain Patients Can Find Long-Term Success Using Cannabis
Many users report immediate pain relief from using medical cannabis, but now a recently published study suggests chronic ...
APR 14, 2021
Cannabis Sciences
Why Delta-8-THC is Different to Regular THC
APR 14, 2021
Why Delta-8-THC is Different to Regular THC
In recent months, a cannabinoid known as delta-8-tetrahydrocannabinol (THC) has increased in popularity. While similar t ...
APR 16, 2021
Microbiology
A New Kind of COVID-19 Vaccine
APR 16, 2021
A New Kind of COVID-19 Vaccine
The current COVID-19 vaccines by Pfizer/BioNTech and Modern are based on messenger RNA, which cells use to make proteins ...
Loading Comments...